Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

Helsinki University Central Hospital (HUCH)

Status: Completed

Conditions: COVID-19; Extracorporeal Membrane Oxygenation Complication; Acute Respiratory Distress Syndrome

Treatments: Device: Extracorporeal membrane oxygenation

Study type: Observational

Funder types: Other

Identifiers

NCT04383678

COVID-19 ECMO

Details and patient eligibility

About

This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.

Full description

We evaluated the outcome of adult patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) requiring the use of extracorporeal membrane oxygenation (ECMO).

Enrollment: 132 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• PCR-confirmed or suspected COVID-19 infection with ARDS who require any ECMO therapy

Exclusion criteria

• None

Trial design

132 participants in 1 patient group

COVID-19 positive patients

Treatment:

Device: Extracorporeal membrane oxygenation